Medical Grade Skincare Market by Product (Cleansers, Gels, Creams & Moisturizers, Masks & Serums), Active Ingredients (Alpha Hydroxy Acids, Ceramides, Ferulic Acid), Packaging Type, Indication, Distribution Channels, Revenue Distribution - Global Forecast 2024-2030
The Medical Grade Skincare Market size was estimated at USD 96.82 billion in 2023 and expected to reach USD 104.30 billion in 2024, at a CAGR 8.19% to reach USD 168.06 billion by 2030.
Medical-grade skincare products are formulated with high-quality, potent ingredients and are usually available through licensed healthcare professionals such as dermatologists and physicians. Medical-grade skincare products are designed to address skin concerns and are often backed by scientific research and clinical testing. Medical-grade skincare products are generally formulated with higher concentrations of active ingredients such as retinoids, alpha hydroxy acids (AHAs), beta hydroxy acids (BHAs), antioxidants, and peptides. The growing demand for skin care products that offer advanced solutions and target specific skin concerns such as aging, acne, hyperpigmentation, and skin sensitivity is elevating the need for medical-grade skincare products. Limited availability and distribution channels that restrict consumer access, particularly those in remote areas with fewer healthcare professionals, hamper the market growth. The rising incorporation of cutting-edge technologies such as encapsulation systems, nanotechnology, and advanced delivery systems in medical-grade skincare products is expected to create opportunities for market growth.
Regional Insights
The presence of advanced healthcare infrastructure, rising consumer awareness, and strong demand for innovative skincare solutions are the factors responsible for the growth of the medical grade skin care market in the Americas. Consumers in the Americas increasingly prefer anti-aging skincare, and sun protection, which address specific skin concerns such as acne, hyperpigmentation, and rosacea, thereby creating a platform for the medical grade skin care market in the Americas. With the increasing influence of K-beauty and J-beauty trends, there is a growing interest in advanced skincare solutions and medical grade skincare products in Asia-Pacific to address specific skin concerns. Europe, with countries such as Germany, France, the United Kingdom, Italy, and Spain, represents a developing landscape for the medical grade skincare market owing to the well-established distribution networks, advanced healthcare systems, and a strong emphasis on skincare. Platforms, including eCommerce, are gaining significant traction in the Americas, Europe, and Asia-Pacific region, allowing medical-grade skincare brands to reach a broader customer base.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Medical Grade Skincare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Increasing consumer inclination and awareness regarding the importance of skin health
Growing popularity of nonsurgical aesthetic procedures and utilization of medical grade skincare products
Market Restraints
Limited consumer awareness associated with medical grade skincare products
Market Opportunities
Development of new medical grade skincare products and formulations
Expanding accessibility and availability of medical grade skincare products on online channels
Market Challenges
Possible risks of products due to negative reactions to skin
Market Segmentation Analysis
Product: Rising demand for medical grade skincare products which can suit various skin types
Active Ingredients: Growing potential of hyaluronic acid due to its incredible capacity to retain moisture
Packaging Type: Increasing inclination towards dispensing tube-type medical grade skincare products due to its convenience and ease of use
Indication: Rising usage of medical grade skin care products to manage acne that helps to unclog pores and reduce inflammation
Distribution Channels: Growing availability of medical grade skincare products across online platforms as they offer convenience and broader selection
Revenue Distribution: Rising sell-out revenue with increasing consumption of medical grade skincare
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Grade Skincare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Grade Skincare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Shiseido to Acquire Dr. Dennis Gross Skincare
Shiseido Company, Limited announced a significant expansion in its skincare portfolio through its subsidiary Shiseido Americas Corporation. The company has reached a definitive agreement to acquire DDG Skincare Holdings LLC, the proprietor of the acclaimed Dr. Dennis Gross Skincare brand. Renowned for its dermatologist-formulated, science-driven prestige skincare products, Dr. Dennis Gross Skincare has made a profound impact in the beauty sector by delivering advanced, clinic-quality formulations to a broad consumer base. This strategic acquisition underscores Shiseido's commitment to pioneering skincare innovation and enhancing its market position in the high-performing medical grade skincare category.
Revision Skincare Unveils ‘Science Is Black and White’ Brand Campaign Alongside New Innovation
Revision Skincare unveiled a compelling brand campaign named “The Science Is Black and White,” which underscores the brand's unwavering commitment to delivering results-oriented skincare solutions. Drawing on their extensive history of formulating products with proven efficacy, the campaign asserts a clear message: there is absolute certainty in the science behind their skincare. Coinciding with this initiative, Revision Skincare is introducing a new aesthetic on their website and social media platforms, featuring striking black and white visuals that reflect the campaign's theme.
Galderma Announces Launch in the UK and Direct Distribution and Expansion in Canada
Galderma's Alastin Skincare extended its reach, marking a notable debut in Mexico. The brand is poised for continued growth with an eagerly anticipated launch in the United Kingdom, further solidifying its global presence. In a strategic move to simplify operations and enhance market penetration, the brand is transitioning to direct management under Galderma in the Canadian sphere.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Grade Skincare Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medical Grade Skincare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALASTIN Skincare, Inc. by Galderma Laboratories, L.P., Alkem Laboratories Ltd., AllerganAesthetics, Alpyn Beauty, AlumierMD Labs, Inc., AMP Medical, LLC, Aspect Skincare by Advanced Skin Technology Pty Ltd., Audaja Inc., Augustinus Bader, Beiersdorf AG, Bioderma, Cipla Limited, Colgate-Palmolive Company, CosMedical Technologies, Cosmetic Solutions, DefenAge by Progenitor Biologics, LLC, DERMAdoctor, LLC by NovaBay Pharmaceuticals, Eau Thermale Avene by Pierre Fabre Group, Environ Skin Care (Pty) Ltd., Epicutis, Episciences, Inc., ESK Care Pty Limited, Estée Lauder Companies Inc., Evolve Med Spa, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Honasa Consumer Ltd., Image Skincare, INSKIN Cosmedics Group Pty Ltd., Inspira Skin, iS Clinical, Jan Marini Skin Research, L'Oréal S.A., NEOCUTIS by Merz North America, Inc., NeoStrata Company, Inc. by Johnson & Johnson Services, Inc., Obagi Cosmeceuticals LLC, Piramal Pharma Limited, Revision Skincare, Sebapharma GmbH & CO. KG, Sente, Inc., Shiseido Company, Limited, Skin + Me, The Skincare Company, Topix Pharmaceuticals, Inc., Trilogy Laboratories, LLC, Unilever PLC, USRx LLC, and ZO Skin Health, Inc..
Market Segmentation & Coverage
This research report categorizes the Medical Grade Skincare Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Cleansers
Gels, Creams & Moisturizers
Masks & Serums
Active Ingredients
Alpha Hydroxy Acids
Ceramides
Ferulic Acid
Hyaluronic Acid
Kojic Acid
Salicylic Acid
Vitamins
Vitamin A
Vitamin B
Vitamin C
Vitamin E
Vitamin K
Packaging Type
Bottle
Dispensing Pumps
Tube
Indication
Acne
Age Spots
Dry Skin
Fine Lines & Winkles
Hyperpigmentation
Skin Laxity
Sun Damage
Distribution Channels
Offline
Dermatology Clinics
Physicians
Online
Revenue Distribution
Sell-in
Sell-out
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New Jersey
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing consumer inclination and awareness regarding the importance of skin health
5.1.1.2. Growing popularity of nonsurgical aesthetic procedures and utilization of medical grade skincare products
5.1.2. Restraints
5.1.2.1. Limited consumer awareness associated with medical grade skincare products
5.1.3. Opportunities
5.1.3.1. Development of new medical grade skincare products and formulations
5.1.3.2. Expanding accessibility and availability of medical grade skincare products on online channels
5.1.4. Challenges
5.1.4.1. Possible risks of products due to negative reactions to skin
5.2. Market Segmentation Analysis
5.2.1. Product: Rising demand for medical grade skincare products which can suit various skin types
5.2.2. Active Ingredients: Growing potential of hyaluronic acid due to its incredible capacity to retain moisture
5.2.3. Packaging Type: Increasing inclination towards dispensing tube-type medical grade skincare products due to its convenience and ease of use
5.2.4. Indication: Rising usage of medical grade skin care products to manage acne that helps to unclog pores and reduce inflammation
5.2.5. Distribution Channels: Growing availability of medical grade skincare products across online platforms as they offer convenience and broader selection
5.2.6. Revenue Distribution: Rising sell-out revenue with increasing consumption of medical grade skincare
5.3. Market Trend Analysis
5.3.1. Presence of major regional market vendors focusing on the introduction of clinically new formulations in Americas
5.3.2. Growing popularity of K-beauty and J-beauty expanding the scope of medical grade skincare products in Asia-Pacific region
5.3.3. Growing awareness about skincare coupled with an emphasis on personal grooming in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Medical Grade Skincare Market, by Product
6.1. Introduction
6.2. Cleansers
6.3. Gels, Creams & Moisturizers
6.4. Masks & Serums
7. Medical Grade Skincare Market, by Active Ingredients
7.1. Introduction
7.2. Alpha Hydroxy Acids
7.3. Ceramides
7.4. Ferulic Acid
7.5. Hyaluronic Acid
7.6. Kojic Acid
7.7. Salicylic Acid
7.8. Vitamins
8. Medical Grade Skincare Market, by Packaging Type
8.1. Introduction
8.2. Bottle
8.3. Dispensing Pumps
8.4. Tube
9. Medical Grade Skincare Market, by Indication
9.1. Introduction
9.2. Acne
9.3. Age Spots
9.4. Dry Skin
9.5. Fine Lines & Winkles
9.6. Hyperpigmentation
9.7. Skin Laxity
9.8. Sun Damage
10. Medical Grade Skincare Market, by Distribution Channels
10.1. Introduction
10.2. Offline
10.3. Online
11. Medical Grade Skincare Market, by Revenue Distribution
11.1. Introduction
11.2. Sell-in
11.3. Sell-out
12. Americas Medical Grade Skincare Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Medical Grade Skincare Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Medical Grade Skincare Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Shiseido to Acquire Dr. Dennis Gross Skincare
15.3.2. Revision Skincare Unveils ‘Science Is Black and White’ Brand Campaign Alongside New Innovation
15.3.3. Galderma Announces Launch in the UK and Direct Distribution and Expansion in Canada
15.3.4. INSKIN COSMEDICS Secures Funding to Accelerate Growth
15.3.5. Alumier Introduces its Latest Refining Clay Mask
15.3.6. Skin Pharm Raises USD 15 Million To Expand Clinics, Scale Aesthetic Dermatology Practice
15.3.7. Skin Rx Launches Preventive, Medical-Grade Skincare for Gen Z
15.3.8. Hand & Stone Further Invests into Skin Care and Facial Enhancements
15.3.9. GetHarley Raises USD 52 million to Connect Consumers With World-Class Clinicians and Medical-Grade Skincare Products
15.3.10. AlumierMD Unveils New Wellness Assets
15.3.11. UK-based Skin + Me secures over EUR 11 million for its Personalized Prescription-Based Approach To Skincare
15.3.12. Evolve Med Spa Launches Medical-Grade Skincare Line